Microscopic: dipstick ≥1+ blood, microscopy ≥5 RBCs/hpf
Need two samples to make diagnosis
Gross (macroscopic): visible blood in urine and blood present on microscopy
Always ensure any postmenarchal girls are not on menses when sample was taken (high risk of contamination)
Lysis of RBCs due to urine dilution
Myoglobinuria (rhabdomyolysis)
Hemoglobinuria (intravascular hemolysis)
Thorough history can help distinguish between glomerulonephritis, hypercalciuria, stones, urinary tract disorders
Recent illnesses?
Sore throat (pharyngitis) in the past 1-2 weeks or rash (impetigo) in the past 6 weeks would suggest post-infectious glomerulonephritis (PIGN)
Painful urination (dysuria), urinary urgency, ↑ urinary frequency,
If postmenarchal girl: active menses? (High risk of contamination)
Blood pressures: if normotensive, makes GN less likely
Note: ensure you know the patient's age and most recent height to be able to plot the blood pressure appropriately
Ensure no urethral meatus present
Urine
Urinalysis w/ microscopy
Urine protein/creatinine ratio (UPC) from first morning void
Consider urine calcium/creatinine ratio (UCa/Cr)
Blood
Kidney function panel (BMP+Ca+Albumin+PO4)
Antistreptolysin O (ASO)
C3
Antinuclear antibody (ANA)
Imaging
Consider ultrasound (e.g., if concerned for anatomic abnormality, obstructing kidney stone)
Biopsy
May be indicated if significant hematuria and/or concomitant proteinuria
Differential:
Tuberculosis
MR urogram: Putty
Frequency, urgency
Bilobed cysts
Oxybutynin
Enlarged kidneys
Renal TB
Caused by Mycobacterium tuberculosis, a low growing gram positive bacillus
>95% airborne transmission; less commonly transplacental and sexual transmission
5-45% of TB patients have extrapulmonary TB
Common sites: lymph nodes, pleura, bones, meninges, urogenital tract
Via hematogenous or lymphatic spread
Most frequently diagnosed presentation of urogenital TB
Up to 10% have active TB, CXR abnormal in 50%
Usually bilateral
Granulomas and caseous necrosis can occur throughout the renal tissue, particularly in the cortex or peritubular capillary bed ("putty kidney")
Can progress to tubulointerstitial nephritis, papillary necrosis, eventually calcifications
Dissemination into renal pelvis can lead to tuberculous pyelonephritis, scarring of the renal pelvis/ UPJ, and urinary flow obstruction leading to dilated calyces
Can also see RPGN, crescentic GN, membranous nephropathy
Ureteric TB
Can involve any part of the ureter
TB of ureters without renal TB has NOT been described
Seen in up to 50% of patients with renal tB
Mtb spreads from renal medullary lesions to the ureters in bladder
Granulomas form in the mucosa -> inflammation, ulceration and fibrosis -> stricture formation, obstruction, reflux
Bladder TB
Usually secondary to renal TB (21%)
Spread from primary or secondary lesions elsewhere or retrograde from testicular or prostatic TB
Tuberculomas
Narrowing of UJV due to chronic inflammation and fibrosis -> ureterovesical reflux and hydroureteronephrosis
Thimble bladder - small capacity, irregular bladder due to chronic inflammation and progressive thickening wall with calcifications
Bladder perforation and fistula fistula formation (Vesicovaginal, vesicocolic, etc.)
Urinary TB
Many asymptomatic early on
Autopsy studies reveal ~50% of patients with renal TB reported to have symptoms
Can present with dysuria, increased frequency and urgency, or flank pain
UA - Cx negative, sterile pyuria
Not usually with constitutional symptoms
Diagnosis: 3 early morning urine samples with acid-fast stain, mycobacterial culture, and PCR for Mtb
Urine mycobacterial culture - wide range of sensitivity (10-90%)
Urine AFB stain - SN 30-40%, can be false positive as nontuberculous mycobacterium can be in urine
Urine PCR - SN 87-100%
Renal biopsy (if done) - granulomas, presence of acid fast Mtb bacilli
Treatment: Anti-tB drugs mainstay of treatment
Surgical intervention necessary in upt o50% of cases
Urinary obstruction, abscess, nephrectomy for nonfunctioning kidneys, ureter reconstruction, bladder reconstruction to improve functional bladder capacity
Relapse of urogenital TB can occur after initial urine sterilization in up to 6% of cases after a mean of 5 years of treatment
Therefore, surveillance is warranted for 10 years (screening every 6-12 months)
Medical:
oxybutynin, solifenacin
Mirabegron (beta-3 agonist)
[AMA formatted citations]
***